Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Kensey Nash Corp. (KNSY) Receives FDA Clearance for Vessel Wall Detection Technology

Kensey Nash Corp. (KNSY), headquartered in Exton, Pennsylvania, is a medical technology company that provides innovative solutions and technologies for a wide range of medical procedures. The company provides an extensive range of products for multiple medical markets, primarily in the endovascular, sports medicine and spinal markets. Kensey has also commercialized a series of innovative products through its own direct endovascular sales force.

Recently, the company received 510K clearance for an important vessel-wall detection technology from the U.S. Food and Drug Administration. The technology was designed to enhance the guidance provided by the Safe-Cross® RF CTO System. The Safe-Cross System combines a forward-looking guidance system and radio frequency (RF) energy to safely cross and recanalize chronic total occlusions in the coronary and peripheral arteries.

Safe-Cross consoles incorporating the new technology will undergo a period of user evaluations prior to broader market introduction. Separately, Kensey has additional improvements underway for the Safe-Cross product line, which will require separate regulatory clearances. Kensey is now finalizing a completely new user interface, designed to simplify the presentation of information important to the physician user. The new user interface, as well as other minor software enhancement, will be introduced in Kensey’s fiscal 2009 year.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *